Prognostic Role of 14F7 Mab Immunoreactivity against N-Glycolyl GM3 Ganglioside in Colon Cancer

Table 3

14F7 Mab immunostaining in relation to clinicopathologic features in colon cancer.

Clinicopathologic features	Level of immunostaining (IRS)
	Low	High	𝑃^∗
Age, years (𝑛=47)			0,098
≤60	8	12
>60	5	22
Sex (𝑛=50)			0,596
Women	8	19
Men	7	16
Tumor location (𝑛=49)			0,841
Sigmoid colon	5	16
Left side colon	1	2
Transverse colon	2	4
Right side colon	7	12
TNM stage (𝑛=50)			0,025
I-II	12	16
III-IV	3	19
Grade of differentiation (𝑛=50)			0,311
Well/moderate	14	29
Poor	1	6
Mucinous type (𝑛=50)			0,602
Yes	4	9
No	11	26
Mitotic index (𝑛=49)			0,550
Low	10	26
Moderate-high	4	9
Grade of cell pleomorphism (𝑛=49)			0,622
Low	6	15
Moderate-high	8	20
Peritumoral inflammation (𝑛=50)			0,596
Low	7	16
High	8	19
Lymphovascular invasion (𝑛=50)			0,524
Yes	1	4
No	14	31

∗Chi-square test; IRS: immunoreactive score; TNM: tumor node metastases.
Bold value indicates statistical significance.